Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1976 1
1978 2
1979 1
1982 3
1983 3
1984 4
1985 8
1986 2
1987 4
1988 2
1989 4
1990 1
1991 3
1992 4
1993 7
1994 7
1995 8
1996 8
1997 3
1998 5
1999 5
2000 3
2001 1
2003 5
2004 3
2006 5
2007 1
2008 5
2009 5
2010 6
2011 3
2012 7
2013 4
2014 3
2015 3
2016 12
2017 12
2018 21
2019 16
2020 6
2021 13
2022 11
2023 12
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

231 results

Results by year

Filters applied: . Clear all
Page 1
Atogepant for the Preventive Treatment of Migraine.
Ailani J, Lipton RB, Goadsby PJ, Guo H, Miceli R, Severt L, Finnegan M, Trugman JM; ADVANCE Study Group. Ailani J, et al. Among authors: finnegan m. N Engl J Med. 2021 Aug 19;385(8):695-706. doi: 10.1056/NEJMoa2035908. N Engl J Med. 2021. PMID: 34407343 Clinical Trial.
Ubrogepant for the Treatment of Migraine.
Dodick DW, Lipton RB, Ailani J, Lu K, Finnegan M, Trugman JM, Szegedi A. Dodick DW, et al. Among authors: finnegan m. N Engl J Med. 2019 Dec 5;381(23):2230-2241. doi: 10.1056/NEJMoa1813049. N Engl J Med. 2019. PMID: 31800988 Clinical Trial.
Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial.
Pozo-Rosich P, Ailani J, Ashina M, Goadsby PJ, Lipton RB, Reuter U, Guo H, Schwefel B, Lu K, Boinpally R, Miceli R, De Abreu Ferreira R, McCusker E, Yu SY, Severt L, Finnegan M, Trugman JM. Pozo-Rosich P, et al. Among authors: finnegan m. Lancet. 2023 Sep 2;402(10404):775-785. doi: 10.1016/S0140-6736(23)01049-8. Epub 2023 Jul 26. Lancet. 2023. PMID: 37516125 Clinical Trial.
Towards International Standards: East Meets West.
Finnegan M, Bayazit H, Cronin T, Guler K, Galligan T, Karababa FI, McLoughlin DM. Finnegan M, et al. J ECT. 2018 Mar;34(1):1-2. doi: 10.1097/YCT.0000000000000478. J ECT. 2018. PMID: 29324523 No abstract available.
Myofascial pain and treatment: Editorial.
Dommerholt J, Hooks T, Chou LW, Finnegan M. Dommerholt J, et al. Among authors: finnegan m. J Bodyw Mov Ther. 2019 Jul;23(3):521-531. doi: 10.1016/j.jbmt.2019.06.009. Epub 2019 Jun 14. J Bodyw Mov Ther. 2019. PMID: 31563365
Building related illness.
Finnegan MJ, Pickering CA. Finnegan MJ, et al. Clin Allergy. 1986 Sep;16(5):389-405. doi: 10.1111/j.1365-2222.1986.tb01974.x. Clin Allergy. 1986. PMID: 3536169 Review. No abstract available.
231 results